Genetic cause of childhood leukemia discovered

Genetic cause of childhood leukemia discovered
Published on: 

Scientists have for the first time identified  an inherited genetic mutation linked to increased risk of developing  the most common type of childhood leukemia.

The discovery was made by a team of researchers from Memorial Sloan-Kettering  Cancer Center, St Jude Children's Research Hospital, University of  Washington, and other institutions.

"At the very least this discovery gives us a new window into inherited  causes of childhood leukemia. More immediately, testing for this  mutation may allow affected families to prevent leukemia in future  generations," said study author Kenneth Offit, Chief of the Clinical  Genetics Service at Memorial Sloan-Kettering.

The mutation was first observed in a family treated at Memorial  Sloan-Kettering of which several family members of different generations  had been diagnosed with childhood acute lymphoblastic leukemia (All). A second, non-related, leukemia-prone family cared for at a different  hospital was later found to have the same mutation.

A series of experiments were conducted confirming that the observed  mutation compromised the normal function of the gene, which may increase  the risk of developing All. The inherited genetic mutation is located in a gene called PAX5,  which is known to play a role in the development of some B cell cancers,  including All.

PAX5, a transcription factor or "master gene," regulates the activity  of several other genes and is essential for maintaining the identity  and function of B cells. In all study participants, one of the two copies of the PAX5 gene  was missing, leaving only the mutated version. The newly discovered gene mutation may someday help scientists determine  how to target transcription factors to treat other non-inherited  forms of leukemia where the PAX5 mutation is present.

"With a better understanding of the genetic elements that induce  cancer susceptibility, or drive cancer to grow, we can more precisely  target therapy as well as potentially prevent cancer from occurring  in the first place," added Offit. The discovery was published in the journal Nature Genetics.

Daily Pioneer
dailypioneer.com